Dr Andrew Irving
No more applications being accepted
Funded PhD Project (European/UK Students Only)
About the Project
Applications are invited for a 4 year PhD position to explore the pharmacology and pathophysiological role of novel G-protein coupled receptor (GPCR) therapeutic targets in the CNS. The work will be directed towards neurodegenerative disease (Alzheimer’s), neuroimmune function and the regulation of synaptic plasticity. This would be particularly suited to students interested in research at the interface between drug discovery and neuroscience, located in one of the most vibrant cities in Europe!
The successful candidate will gain experience in a variety of experimental techniques, including cell culture, advanced microscopy and cellular imaging as well as in vitro GPCR signalling assays and electrophysiological recording. The project will be based in the laboratory of Dr Andrew Irving, who has recently moved to University College Dublin. It will also involve our extensive collaborative links within academia and the pharmaceutical industry, with the opportunity for a 3-6 month placement within a UK-based pharmaceutical company.
For further information feel free to contact Dr Andrew Irving by email: [Email Address Removed]
Applicants should email a copy of their CV with the names of two academic referees by 6th March 2015 to: [Email Address Removed]
Funding Notes
This studentship is open to all EU citizens.
Start date: September 2015
Stipend: €15,000 per year. Note, students will need to cover a €3,000 per year tuition fee, but may be able to earn additional income.
Other Requirements: Undergraduate degree in Pharmacology, Neuroscience, Biochemistry or a related biomedical discipline at 2:1 or above (or EU equivalent).
Experience of molecular pharmacology, neuroscience or microscopy techniques would be advantageous. The candidate should also have good communication skills, be able to work independently and thrive within a multi-disciplinary research environment.
Continue with Facebook
